120 related articles for article (PubMed ID: 33016076)
1. The potential role of the eGFR in differentiating between true and pseudohyperkalaemia.
Morris TG; Lamba S; Fitzgerald T; Roulston G; Johnstone H; Mirzazadeh M
Ann Clin Biochem; 2020 Nov; 57(6):444-455. PubMed ID: 33016076
[TBL] [Abstract][Full Text] [Related]
2. A case of severe pseudohyperkalaemia due to muscle contraction.
Van Elslande J; Dominicus T; Toelen J; Frans G; Vermeersch P
Biochem Med (Zagreb); 2020 Jun; 30(2):021004. PubMed ID: 32550820
[TBL] [Abstract][Full Text] [Related]
3. Investigation of outpatients referred to a chemical pathologist with potential pseudohyperkalaemia.
Kapoor AK; Ravi A; Twomey PJ
J Clin Pathol; 2009 Oct; 62(10):920-3. PubMed ID: 19783721
[TBL] [Abstract][Full Text] [Related]
4. Leaky cell syndrome: a rare cause of pseudohyperkalaemia.
Lukens MV; de Mare A; Kerbert-Dreteler MJ; van den Bergh FA
Ann Clin Biochem; 2012 Jan; 49(Pt 1):97-100. PubMed ID: 22042978
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and factors associated with false hyperkalaemia in Asians in primary care: a cross-sectional study (the Unlysed Hyperkalaemia- the Unseen Burden (UHUB) study).
Boo AYY; Koh YLE; Hu PL; Tan NC
BMJ Open; 2020 Sep; 10(9):e033755. PubMed ID: 32963061
[TBL] [Abstract][Full Text] [Related]
6. [Must we always treat hyperkalaemia?].
Basile C; Manobianca G; Bruno A; Tamma F
G Ital Nefrol; 2013; 30(1):. PubMed ID: 23832444
[TBL] [Abstract][Full Text] [Related]
7. A case of undiagnosed pseudohyperkalaemia following a splenectomy.
Grech M
Age Ageing; 2018 Sep; 47(5):758-759. PubMed ID: 29757348
[TBL] [Abstract][Full Text] [Related]
8. Pseudohyperkalaemia associated with leukaemic cell lysis during pneumatic tube transport of blood samples.
Dickinson H; Webb NJ; Chaloner C; Wynn RF; Bonney DK
Pediatr Nephrol; 2012 Jun; 27(6):1029-31. PubMed ID: 22366875
[TBL] [Abstract][Full Text] [Related]
9. Pseudohyperkalaemia in essential thrombocytosis: an important clinical reminder.
Mizzi JM; Rizzo C; Fava S
Endocrinol Diabetes Metab Case Rep; 2021 Apr; 2021():. PubMed ID: 33960323
[TBL] [Abstract][Full Text] [Related]
10. Implications of differences between point-of-care blood gas analyser and laboratory analyser potassium results on hyperkalaemia diagnosis & treatment.
Pradhan J; Harding AM; Taylor SE; Lam Q
Intern Med J; 2023 Nov; 53(11):2035-2041. PubMed ID: 36645311
[TBL] [Abstract][Full Text] [Related]
11. Hyperkalemia After Initiating Renin-Angiotensin System Blockade: The Stockholm Creatinine Measurements (SCREAM) Project.
Bandak G; Sang Y; Gasparini A; Chang AR; Ballew SH; Evans M; Arnlov J; Lund LH; Inker LA; Coresh J; Carrero JJ; Grams ME
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28724651
[TBL] [Abstract][Full Text] [Related]
12. Evaluating the risk of hyperkalaemia and acute kidney injury with cotrimoxazole: a retrospective observational study.
Rajput J; Moore LSP; Mughal N; Hughes S
Clin Microbiol Infect; 2020 Dec; 26(12):1651-1657. PubMed ID: 32220637
[TBL] [Abstract][Full Text] [Related]
13. [Risk for hyperkalemia during long-term treatment with angiotensin-converting enzyme inhibitors in insulin-dependent type 2 diabetics in relation to the glomerular filtration rate].
Raml A; Schmekal B; Grafinger P; Biesenbach G
Dtsch Med Wochenschr; 2001 Nov; 126(47):1327-30. PubMed ID: 11719857
[TBL] [Abstract][Full Text] [Related]
14. The impact of centrifugation in primary care on pseudohyperkalaemia: a retrospective evaluation.
Turner HE; Peake RW; Allison JJ
Ann Clin Biochem; 2013 Jul; 50(Pt 4):371-3. PubMed ID: 23761382
[TBL] [Abstract][Full Text] [Related]
15. Pseudohyperkalaemia is a common finding in myeloproliferative disorders that may lead to inappropriate management of patients.
Ong YL; Deore R; El-Agnaf M
Int J Lab Hematol; 2010 Feb; 32(1 Pt 1):e151-7. PubMed ID: 19016918
[TBL] [Abstract][Full Text] [Related]
16. Pseudohyperkalaemia in thrombocythaemia.
Wulkan RW; Michiels JJ
J Clin Chem Clin Biochem; 1990 Jul; 28(7):489-91. PubMed ID: 2230668
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of eplerenone in patients at high risk for hyperkalemia and/or worsening renal function: analyses of the EMPHASIS-HF study subgroups (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure).
Eschalier R; McMurray JJ; Swedberg K; van Veldhuisen DJ; Krum H; Pocock SJ; Shi H; Vincent J; Rossignol P; Zannad F; Pitt B;
J Am Coll Cardiol; 2013 Oct; 62(17):1585-93. PubMed ID: 23810881
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the concurrent use of potassium-influencing drugs as risk factors for the development of hyperkalemia.
Kuijvenhoven MA; Haak EA; Gombert-Handoko KB; Crul M
Int J Clin Pharm; 2013 Dec; 35(6):1099-104. PubMed ID: 23974985
[TBL] [Abstract][Full Text] [Related]
19. [Prevalence and related factors of hyperkalemia in patients with diabetic kidney disease].
Li SY; Li GP; Wang L; Duan JY; Chen WQ; Pan SK; Liu ZS; Liu DW
Zhonghua Yi Xue Za Zhi; 2021 Nov; 101(42):3478-3483. PubMed ID: 34775705
[No Abstract] [Full Text] [Related]
20. ACE-inhibitor or AT2-antagonist therapy of renal transplant recipients is associated with an increase in serum potassium concentrations.
Mitterbauer C; Heinze G; Kainz A; Kramar R; Hörl WH; Oberbauer R
Nephrol Dial Transplant; 2008 May; 23(5):1742-6. PubMed ID: 18234845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
